Home Equities Score ASLAN Pharmaceuticals (ASLN) Stock sees 70% stock price increase due to successful...

ASLAN Pharmaceuticals (ASLN) Stock sees 70% stock price increase due to successful first trial report

ASLAN Pharmaceuticals (NASDAQ: ASLN) moved upward an impressive 73.58% and has reached a share price of $7.69. ASLAN had previously closed at $4.43. This all happened in the pre-market Monday trading session.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Operational Biodata

Aslan Pharmaceuticals Ltd was founded in 2010. It is a biotech pharmaceutical company with headquarters in Singapore. ASLAN (NASDAQ: ASLN) specializes in clinical-stage immunology and oncology for the treatment of patients. Specifically, it has a focused-area-of-expertise in running test treatments for atopic dermatitis and small-molecule inhibitor that targets oncology.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Read More

ASLAN Phase 1 Trial Successful!

The jump in the pre-market trade arose due to an announcement made today about a certain treatment called ASLAN004 which is a monoclonal therapy used essentially to treat atopic dermatitis and other immunology indications. The press-release that is referring to the scientific-specific terminology is highlighted here.

“positive interim unblinded data from the three dose cohorts of its ongoing randomized, double-blind patio placebo-controlled multiple ascending dose study of ASLAN004 for the treatment of moderate to severe atopic dermatitis.”

In laymen’s term what this string of scientific-pharmaceutical jargon means is that the monoclonal therapy ASLAN004 was run through several excessive tests where test-subjects were placed in the control group and placebo group, where the patients placed in the control group were given ASLAN dosage that showed efficacy compared to the group which was given placebo effect.

Biotech Penny Stock

The ASLAN pharmaceutical is a penny stock and penny stocks have a tumultuous reaction towards business cycles. When the stock market seems to be plummeting or breaking down, these biotech penny stocks tend to soar and they plunge when the market is rising. These penny stocks have an inverse relation with the fall & rise of the stock market because the factors they depend on are different.

Another factor that is really associated with the rise and decline of these biotech penny stocks is that pharmaceutical companies have clinical tests and trials that they run for different drugs and treatments. When news of the success of the treatment or (FDA) approval of the drug is verified then this news really soars up the prices of the stock as the sentiment around the stock becomes positive.

$18 million security purchase agreement

Investors also look forward to news of mergers, deals, business licensing, and approvals to determine the movement of the stock. On 25th February, ASLAN pharmaceuticals had announced the security purchase deal that it entered into through a private placement to Surveyor Capital and Vivo Capital, which are relatively new institutional investors. The agreement allows the acquiring and raising of $18 million gross proceeds resulting from the sale of its ordinary purchases.

The terms of the securities purchase agreement state that the company will issue 5,113,636 American Depository Shares at a price per share of $3.52 which is equivalent to the last closing price of the Company’s ADS.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Watch Out For Second Phase Trials

This interim data is from the ongoing study of the phase 1 clinical trial test which is very significantly positive news. However 1st phase also means that there are more phases to come which will determine the true authenticity and efficacy of the ASALN004, thus ASLAN (NASDAQ: ASLN) stock should be the biotech penny stock that investors need to keep a close eye on, this year. The pharmaceutical company plans on starting the 2b phase of the trials this year, which will be sooner now due to a successful first phase trial as compared to prolonged delay if the trials were unsuccessful.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Did The CMCL Stock Rise By 8% In Last Trading?

Caledonia Mining Corporation Plc (NYSE: CMCL) gained 8.91% during the trading session on Thursday. The share price reached a low of $13.70 and a...

Why Progyny Inc (PGNY) stock gained on Thursday, April 15?

Progyny Inc (PGNY) stock gained 7.31% in the after-hours session on Thursday, April 15, 2021, after it gained 0.94% in the early session.  PGNY...

Here is Dolphin Entertainment Inc (DLPN) stock turnaround on Thursday, April 15, 2021

Dolphin Entertainment Inc (DLPN) stock was facing negativity in the normal trading session on Thursday, April 15, 2021. It lost 8.05% in the morning...

Why Is TAOP Stock Increasing Today?

Taoping Inc. (NASDAQ: TAOP) is rising on the charts today with a gain of 18.04% to trade at $7.33 at last check-in early trading. Yesterday,...

Is VIZSF Stock Price Up This Past Session?

At the previous close, shares of Vizsla Silver Corp. (OTCQB: VIZSF) were up 8.41% to $1.41. A total of 201,300 shares of Vizsla Silver...

How Did The KXIN Stock Rise In The Last Session?

On Thursday, more than 15.02 million shares of Kaixin Auto Holdings (NASDAQ: KXIN) were traded, and the closing share price was $2.56, an increase...

Why Did The CMCL Stock Rise By 8% In Last Trading?

Caledonia Mining Corporation Plc (NYSE: CMCL) gained 8.91% during the trading session on Thursday. The share price reached a low of $13.70 and a...

What Led The AKUS Stock To Increase On Thursday?

In its Thursday trading session, Akouos Inc. (NASDAQ: AKUS) rose by 8.08%, or $1.16, compared with its previous market close price. The lowest price...

Related News

What Happened On Thursday To Make MMEX Stock Drop?

MMEX Resources Corporation (OTCPink: MMEX) closed yesterday at $0.00135, a drop of -6.90%. The volume of trading for MMEX stock was 302.59M which was...

ALPP Stock Fell 8% On Thursday, Why?

The leading operator and owner of small market businesses, Alpine 4 Holdings, Inc. (OTCQBX: ALPP) closed Thursday's regular trading session at $3.24 a share,...

Did Anything Boost HCMC Stock Last Trading?

On Thursday, shares of Healthier Choices Management Corp. (OTCPink: HCMC) gained 4.5%, touching a low of $0.0011 and a high of $0.0012. In the...

Why Did ENZC Stock Plummet In Last Trading?

Enzolytics Inc. (OTCPINK: ENZC) has been trading in a $0.1133 to $0.1435 range, closing its last trading day down -4.73 percent at $0.1248. Enzolytics...

Do You Know Why ABML Stock Dropped 4% On Thursday?

American Battery Metals Corporation (OTCQB: ABML) stock lost -4.35% on the last trading session when the stock closed at $1.32.  An American Battery Metals...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.